Compounds > 2-chloroadenine
Page last updated: 2024-08-26

2-chloroadenine and MS (Multiple Sclerosis)

2-chloroadenine has been researched along with MS (Multiple Sclerosis) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekblom, M; Karlsson, MO; Munafo, A; Novakovic, AM; Savic, RM1

Trials

1 trial(s) available for 2-chloroadenine and MS (Multiple Sclerosis)

ArticleYear
Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis.
    Clinical pharmacokinetics, 2017, Volume: 56, Issue:10

    Topics: Adenine; Administration, Intravenous; Administration, Oral; Adult; Aged; Cladribine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Models, Biological; Multiple Sclerosis

2017